β-Fibrinogen Gene -455 G/A Polymorphism in Korean Ischemic Stroke Patients
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background and Purpose: We investigated the relationship between the β-fibrinogen gene (FGB) -455 G/A polymorphism and plasma fibrinogen levels in Korean ischemic stroke patients. We also determined whether the frequency of the -455 G/A polymorphism differed between two subtypes of noncardioembolic stroke: large-artery atherosclerosis (LAA) and small-vessel occlusion (SVO). Methods: A total of 267 patients with noncardioembolic stroke were enrolled. Plasma fibrinogen and other risk factors for stroke were evaluated. FGB -455 G/A genotypes were determined by polymerase chain reaction with restrictive enzyme Hae III and automatic DNA sequencing. Results: The FGB -455 G/A polymorphism was significantly associated with an elevated plasma fibrinogen level (p<0.001). The frequency of the A allele in Korean stroke patients was 16.7%. However, the frequency of the -455 G/A polymorphism did not differ between LAA and SVO. Conclusions: The plasma fibrinogen level might be affected by the -455 G/A polymorphism in noncardioembolic stroke patients. However, the LAA and SVO subtypes of ischemic stroke were not affected by the -455 G/A polymorphism.
Abstract
Background and Purpose: We investigated the relationship between the β-fibrinogen gene (FGB) -455 G/A polymorphism and plasma fibrinogen levels in Korean ischemic stroke patients. We also determined whether the frequency of the -455 G/A polymorphism differed between two subtypes of noncardioembolic stroke: large-artery atherosclerosis (LAA) and small-vessel occlusion (SVO). Methods: A total of 267 patients with noncardioembolic stroke were enrolled. Plasma fibrinogen and other risk factors for stroke were evaluated. FGB -455 G/A genotypes were determined by polymerase chain reaction with restrictive enzyme Hae III and automatic DNA sequencing. Results: The FGB -455 G/A polymorphism was significantly associated with an elevated plasma fibrinogen level (p<0.001). The frequency of the A allele in Korean stroke patients was 16.7%. However, the frequency of the -455 G/A polymorphism did not differ between LAA and SVO. Conclusions: The plasma fibrinogen level might be affected by the -455 G/A polymorphism in noncardioembolic stroke patients. However, the LAA and SVO subtypes of ischemic stroke were not affected by the -455 G/A polymorphism.
참고문헌 (28)
- Wilhelmsen L, "Fibrinogen as a risk factor for stroke and myocardial infarction", N Engl J Med, 311, pp.501~505 (1984)
- Maresca G, "Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update", Arterioscler Thromb Vasc Biol, 19, pp.1368~1377 (1999)
- Danesh J, "Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies", JAMA, 279, pp.1477~1482 (1998)
- Tybjaerg-Hansen A, "A common mutation (G-455→A) in the β-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study", J Clin Invest, 99, pp.3034~3039 (1997)
- Leander K, "The G-455A polymorphism of the fibrinogen beta-gene relates to plasma fibrinogen in male cases, but does not interact with environmental factors in causing myocardial infarction in either men or women", J Intern Med, 252, pp.332~341 (2002)
- Komitopoulou A, "Mutations and polymorphisms in genes affecting hemostasis proteins and homocysteine metabolism in children with arterial ischemic stroke", Cerebrovasc Dis, 22, pp.13~20 (2006)
- Doggen CJ, "Fibrinogen polymorphisms are not associated with the risk of myocardial infarction", Br J Haematol, 110, pp.935~938 (2000)
- Yang Z, "The study of β-fibrinogen gene -455G", A, -148 C, A polymorphisms and their association with plasma fibrinogen levels, pp.Zhonghua Xue Ye Xue Za Zhi, 2000[DOI]
- van’t Hooft FM, "Two common, functional polymorphisms in the promoter region of the β-fibrinogen gene contribute to regulation of plasma fibrinogen concentration", Arterioscler Thromb Vasc Biol, 19, pp.3063~3070 (1999)
- Maumus S, "Analysis of the effect of multiple genetic variants of cardiovascular disease risk on insulin concentration variability in healthy adults of the STANISLAS cohort. The role of FGB -455 G", A polymorphism, 2007, pp.191, 369~376
- Martiskainen M, "Fibrinogen gene promoter -455 A allele as a risk factor for lacunar stroke", Stroke, 34, pp.886~891 (2003)
- Kessler C, "The apolipoprotein E and betafibrinogen G", A-455 gene polymorphisms are associated with ischemic stroke involving large-vessel disease, 1997, pp.17, 2880~2884
- Adams HP Jr, "Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment", Stroke, 24, pp.35~41 (1993)
- Lee AJ, "Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study", Br Heart J, 69, pp.338~342 (1993)
- Maresca G, "Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update", Arterioscler Thromb Vasc Biol, 19, pp.1368~1377 (1999)
- Kofoed SC, "Fibrinogen predicts ischaemic stroke and advanced atherosclerosis but not echolucent, rupture-prone carotid plaques: the Copenhagen City Heart Study", Eur Heart J, 24, pp.567~576 (2003)
- Fuss C, "Fibrinogen: Structure, function, and surface interactions", J Vasc Interv Radiol, 12, pp.677~682 (2001)
- Lane DA, "Role of hemostatic polymorphisms in venous and arterial thrombotic disease", Blood, 95, pp.1517~1532 (2000)
- Di Napoli M, "Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke", Stroke, 32, pp.133~138 (2001)
- Resch KL, "Fibrinogen and viscosity as risk factors for subsequent cardiovascular events in stroke survivors", Ann Intern Med, 117, pp.371~375 (1992)
- Iacoviello L, "Genes encoding fibrinogen and cardiovascular risk", Hypertension, 38, pp.1199~1203 (2001)
- Ohira T, "Risk factors for ischemic stroke subtypes: the Atherosclerosis Risk in Communities study", Stroke, 37, pp.2493~2498 (2006)
- Scarabin PY, "Genetic variation at the β-fibrinogen locus in relation to fibrinogen concentrations and risk of myocardial infarction: the ECTIM study", Arterioscler Thromb, 13, pp.886~891 (1993)
- Nishiuma S, "Genetic variation in the promoter region of the beta-fibrinogen gene is associated with ischemic stroke in a Japanese population", Blood Coagul Fibrinolysis, 9, pp.373~379 (1998)
- Liu Y, "Betafibrinogen gene -455A", G polymorphism and plasma fibrinogen level in Chinese stroke patients, 2002, pp.115, 214~216
- Anderson GM, "Functional characterization of promoter elements involved in regulation of human B beta-fibrinogen expression. Evidence for binding of novel activator and repressor proteins", J Biol Chem, 268, pp.22650~22655 (1993)
- Hollander M, "Carotid plaques increase the risk of stroke and subtypes of cerebral infarction in asymptomatic elderly: the Rotterdam study", Circulation, 105, pp.2872~2877 (2002)
- Tejada J, "Does a relationship exist between carotid stenosis and lacunar infarction?", Stroke, 34, pp.1404~1409 (2003)